Literature DB >> 15278667

Intraoperative changes in blood coagulation and the effectiveness of ulinastatin during liver resection.

M Okida1, O Masako, H Maruya, T Higashi, H Yukaya.   

Abstract

The blood coagulation status of 16 patients undergoing liver resection was monitored by thrombelastograph (TEG). Coagulation test by TEG was performed at three different times: before and one hour after induction of anesthesia and after liver resection. The four variables such as r (reaction time), k (coagulation velocity), ma (maximum amplitude) and me (maximum elasticity) were measured. In 8 patients, Ulinastatin was not administered during the operation and FFP was transfused after the second measurement of TEG (group I). The other 8 patients were administered totally 300,000 units of Ulinastatin after induction until the second measurement of TEG, thereafter FFP was transfused (group II). The TEG showed poor preoperative coagulation state in both groups. In group I, TEG variables showed coagulopathy was exacerbated significantly during liver resection. In group II TEG variables showed no significant changes during operation. Between the two groups there were statistical differences in the TEG variables during the operation. The TEG was useful for monitoring coagulation function during liver resection. It was impossible to improve TEG data by only replacement of FFP. Ulinastatin was useful in normalizing the coagulation function and in preventing the changes in TEG measurements during liver resection.

Entities:  

Year:  1991        PMID: 15278667     DOI: 10.1007/s0054010050043

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  11 in total

1.  Studies of trypsin inhibitor in urine. IV. The trypsin inhibitor in urine and serum of rabbits experimentally infected with streptococcus resulting in glomerulonephritis.

Authors:  A MAYEHIRO
Journal:  Yokohama Med Bull       Date:  1960-06

2.  The excretion of trypsin inhibitor in urine during normal pregnancy.

Authors:  H J FAARVANG
Journal:  Acta Endocrinol (Copenh)       Date:  1959-05

3.  Hepatic resection in the treatment of hepatocellular carcinoma: report of 60 cases.

Authors:  N Nagasue; H Yukaya; Y Ogawa; Y Sasaki; H Akamizu; T Hamada
Journal:  Br J Surg       Date:  1985-04       Impact factor: 6.939

4.  Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion.

Authors:  N Nagasue; H Yukaya; Y Ogawa; S Hirose; M Okita
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

5.  [Effect of urinastatin on disseminated intravascular coagulation].

Authors:  H Inaba; K Kato; N Ohzawa; K Nakayama
Journal:  Nihon Yakurigaku Zasshi       Date:  1986-09

6.  Changes in blood coagulation.

Authors:  K N Von Kaulla; H Kaye; E von Kaulla; T L Marchioro; T E Starzl
Journal:  Arch Surg       Date:  1966-01

7.  Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation.

Authors:  Y G Kang; D J Martin; J Marquez; J H Lewis; F A Bontempo; B W Shaw; T E Starzl; P M Winter
Journal:  Anesth Analg       Date:  1985-09       Impact factor: 5.108

8.  Tolerance of the cirrhotic liver to normothermic ischemia. A clinical study of 15 patients.

Authors:  N Nagasue; H Yukaya; S Suehiro; Y Ogawa
Journal:  Am J Surg       Date:  1984-06       Impact factor: 2.565

9.  Purification and characterization of urinary trypsin inhibitor, UTI68, from normal human urine, and its cleavage by human uropepsin.

Authors:  M Muramatu; S Mori; Y Matsuzawa; Y Horiguchi; Y Nakanishi; M Tanaka
Journal:  J Biochem       Date:  1980-11       Impact factor: 3.387

10.  Platelet dynamics in chronic liver disease with special reference to the role of the spleen.

Authors:  P J Toghill; S Green; F Ferguson
Journal:  J Clin Pathol       Date:  1977-04       Impact factor: 3.411

View more
  5 in total

1.  The effect of ulinastatin on hemostasis in major orthopedic surgery.

Authors:  Jin Young Lee; Ji Young Lee; Jin Young Chon; Ho Sik Moon; Sung Jin Hong
Journal:  Korean J Anesthesiol       Date:  2010-01-31

2.  Effects of ulinastatin on postoperative blood loss and hemostasis in atrioventricular valve surgery with cardiopulmonary bypass.

Authors:  Jae Bum Park; Seong Hyop Kim; Song Am Lee; Jin Woo Chung; Jun Seok Kim; Hyun Keun Chee
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-06-05

3.  Effects of ulinastatin on coagulation in high-risk patients undergoing off-pump coronary artery bypass graft surgery.

Authors:  Na-Young Kim; Jae-Kwang Shim; Seo-Ouk Bang; Jee-Suk Sim; Jong-Wook Song; Young-Lan Kwak
Journal:  Korean J Anesthesiol       Date:  2013-02-15

4.  Effect of ulinastatin on post-operative blood loss and allogeneic transfusion in patients receiving cardiac surgery with cardiopulmonary bypass: a prospective randomized controlled study with 10-year follow-up.

Authors:  Peng Zhang; Hong Lv; Xia Qi; Wenjing Xiao; Qinghua Xue; Lei Zhang; Lihuan Li; Jia Shi
Journal:  J Cardiothorac Surg       Date:  2020-05-14       Impact factor: 1.637

5.  Ulinastatin reduces postoperative bleeding and red blood cell transfusion in patients undergoing cardiac surgery: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Yun-Tai Yao; Neng-Xin Fang; Ding-Hua Liu; Li-Huan Li
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.